Edap Tms (EDAP) Competitors $1.52 -0.01 (-0.33%) As of 07/21/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EDAP vs. NVRO, MGRM, CV, CVRX, SGHT, TLSI, INGN, PROF, ELMD, and RCELShould you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Nevro (NVRO), Monogram Orthopaedics (MGRM), CapsoVision (CV), CVRx (CVRX), Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry. Edap Tms vs. Its Competitors Nevro Monogram Orthopaedics CapsoVision CVRx Sight Sciences TriSalus Life Sciences Inogen Profound Medical Electromed Avita Medical Edap Tms (NASDAQ:EDAP) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability. Does the media prefer EDAP or NVRO? In the previous week, Edap Tms' average media sentiment score of 0.00 equaled Nevro'saverage media sentiment score. Company Overall Sentiment Edap Tms Neutral Nevro Neutral Which has preferable valuation & earnings, EDAP or NVRO? Edap Tms has higher earnings, but lower revenue than Nevro. Edap Tms is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdap Tms$69.18M0.82-$20.58M-$0.62-2.44Nevro$408.52M0.55-$92.21M-$3.05-1.92 Do institutionals and insiders believe in EDAP or NVRO? 62.7% of Edap Tms shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 0.2% of Edap Tms shares are held by insiders. Comparatively, 3.2% of Nevro shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is EDAP or NVRO more profitable? Nevro has a net margin of -16.54% compared to Edap Tms' net margin of -34.45%. Nevro's return on equity of -23.52% beat Edap Tms' return on equity.Company Net Margins Return on Equity Return on Assets Edap Tms-34.45% -51.42% -26.43% Nevro -16.54%-23.52%-10.83% Do analysts prefer EDAP or NVRO? Edap Tms presently has a consensus target price of $8.50, suggesting a potential upside of 462.91%. Nevro has a consensus target price of $5.36, suggesting a potential downside of 8.29%. Given Edap Tms' stronger consensus rating and higher possible upside, analysts clearly believe Edap Tms is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edap Tms 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Nevro 2 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.92 SummaryEdap Tms and Nevro tied by winning 6 of the 12 factors compared between the two stocks. Get Edap Tms News Delivered to You Automatically Sign up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDAP vs. The Competition Export to ExcelMetricEdap TmsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$56.84M$6.73B$5.53B$9.40BDividend YieldN/A1.32%4.00%4.04%P/E Ratio-2.4422.8026.9819.12Price / Sales0.8269.60445.0298.80Price / CashN/A20.4724.9928.17Price / Book1.284.618.145.70Net Income-$20.58M$176.14M$3.24B$257.84M7 Day Performance2.72%2.19%2.58%2.98%1 Month Performance-11.07%3.35%8.39%13.28%1 Year Performance-69.62%4.28%32.70%17.13% Edap Tms Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDAPEdap Tms2.3301 of 5 stars$1.51-0.7%$8.50+462.9%-70.4%$56.84M$69.18M-2.44230NVRONevroN/A$5.85+0.1%$5.36-8.3%-35.8%$224.32M$408.52M-3.091,090MGRMMonogram Orthopaedics0.9865 of 5 stars$5.87+78.4%$5.40-8.0%+162.2%$209.49MN/A-13.0428High Trading VolumeCVCapsoVisionN/A$4.37-4.4%N/AN/A$202.51MN/A0.0090Negative NewsGap DownCVRXCVRx3.1047 of 5 stars$7.35+7.6%$14.50+97.3%-11.4%$191.64M$52.87M-3.37160Positive NewsSGHTSight Sciences1.5663 of 5 stars$3.70+8.5%$4.10+10.8%-54.9%$191.28M$78.11M-3.78210TLSITriSalus Life Sciences2.0852 of 5 stars$4.98+1.8%$10.75+115.9%-17.7%$188.44M$32.14M-4.45106Positive NewsINGNInogen4.3209 of 5 stars$6.71-3.0%$11.00+63.9%-32.0%$180.41M$339.96M-5.831,030PROFProfound Medical2.126 of 5 stars$5.75-1.0%$11.50+100.0%-45.7%$172.79M$10.68M-4.71150Positive NewsELMDElectromed0.9477 of 5 stars$19.30+1.2%$38.00+96.9%+15.2%$161.85M$61.44M25.73160RCELAvita Medical0.884 of 5 stars$5.88+3.2%$16.50+180.6%-46.1%$155.41M$64.25M-2.68130Positive News Related Companies and Tools Related Companies Nevro Competitors Monogram Orthopaedics Competitors CapsoVision Competitors CVRx Competitors Sight Sciences Competitors TriSalus Life Sciences Competitors Inogen Competitors Profound Medical Competitors Electromed Competitors Avita Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EDAP) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edap Tms S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edap Tms With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
